Press Release | Mon Dec 17, 2012 3:50pm EST

BRILINTA (Ticagrelor) Receives Additional Class I Recommendation in Updated ACCF/AHA Guidelines for the Management of STEMI Patients

* Reuters is not responsible for the content in this press release.